Sotalol

Half-Life (t½)
PO: 12h · IV: 12h
Formula
C12H20N2O3S
Molecular Weight
272.36 g/mol
PubChem CID
5253
Aliases
Betapace

Pharmacological Mechanism

Class III antiarrhythmic + non-selective β-adrenergic blocker. Prolongs cardiac action potential via IKr blockade (class III) on top of β-blockade. Used for AF rhythm control + ventricular arrhythmias. QT prolongation requires inpatient initiation in many practices.

Half-Life & Elimination Curve (PO: 12h · IV: 12h)

100%50%25%12.5%0%0h0×t½12h1×t½24h2×t½36h3×t½48h4×t½60h5×t½0×t½ (0h): 100% remaining (~0.964 mg/L)1×t½ (12h): 50% remaining (~0.482 mg/L)2×t½ (24h): 25% remaining (~0.241 mg/L)3×t½ (36h): 12.5% remaining (~0.12 mg/L)4×t½ (48h): 6.3% remaining (~60.2 µg/L)5×t½ (60h): 3.1% remaining (~30.1 µg/L)
Plasma (PO)t½ Decay (12h)Effect Site (ke0)
  • 0×t½0h100% (0.964 mg/L)
  • 1×t½12h50% (0.482 mg/L)
  • 2×t½24h25% (0.241 mg/L)
  • 3×t½36h12.5% (0.12 mg/L)
  • 4×t½48h6.3% (60.2 µg/L)
  • 5×t½60h3.1% (30.1 µg/L)
Elimination t½12h (PO)
Rate Constant (ke)0.0578 h⁻¹
Time to Peak (Tmax)3.88h
Est. Peak (Cmax)0.964 mg/L
Clearance (CL)7.28 L/h
97% Washout (5×t½)60h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References